Ā | NĀ° (%) of patients | ||
---|---|---|---|
Ā | Males | Females | Overall |
Urolithiasis | 112 (16.2) | 226 (35.5) | 338 (25.5) |
Neurogenic bladder | 118 (17.1) | 89 (14.0) | 207 (15.6) |
Benign prostatic hyperplasia | 203 (29.5) | 0 | 203 (15.3) |
Structural bladder pathology | 76 (13.0) | 96 (15.1) | 172 (13) |
Urinary tract instrumentation | 105 (15.2) | 47 (7.4) | 152 (11.5) |
Long-term bladder catheterization | 95 (13.8) | 32 (5.0) | 127 (9.6) |
Non lithiasis ureteral or urethral obstruction | 52 (7.7) | 55 (8.6) | 107 (8.1) |
Anatomical or functional single kidney | 24 (3.5) | 33 (5.2) | 57 (4.3) |
Nephrostomy tube | 26 (3.8) | 28 (4.4) | 54 (4.1) |
Ureter catheter or stent | 8 (1.2) | 7 (1.1) | 15 (1.1) |
Immunocompromised | 92 (13.5) | 123 (19.3) | 215 (16.2) |